CAR-T therapy is becoming a more frequent treatment for Medicare patients with diffuse large B-cell lymphoma, but changes in CAR-T treatments that push it as an earlier line of therapy may change where patients receive the therapy — and ultimately, its cost.

The blood pressure drug Losartan may be able to block a gene found in the blood, angiotensin II receptor type 1 (AGTR1), and improve the effectiveness of chemotherapy, according to a study published June 19 in Science Translational Medicine.

Cancer deaths are down over the past three decades, but cancerphobia is as strong as ever, Washington Post columnist Steven Petrow reported July 5.

The FDA has ordered Miami-based North Shore Medical Center to halt mammogram services over quality issues that may have led to inaccurate results, according to a letter obtained by the Miami Herald. 

Hannibal (Mo.) Regional Healthcare System has received $15 million in state funds to expand services and build a new cancer center in Kirksville, Mo., it announced July 2.

At The University of Texas MD Anderson Cancer Center, research and patient care are inextricably linked. Our approach to research-driven patient care involves using the latest clinical findings and advances to inform how we provide care and facilitate optimal patient outcomes. Patients play a vital role in this process, too. By engaging them throughout our studies, we unlock insights that drive the development of cutting-edge therapies, diagnostics, and breakthrough discoveries that bring us closer to fulfilling our mission to end cancer.  

Patients diagnosed with certain abdominal cancers at Charleston, S.C.-based MUSC Hollings Cancer Center can now get next-day access to follow-up care, the system announced July 2.

Researchers at Tampa-based University of South Florida and Bloomington-based Indiana University found cisplatin is linked to increased hearing loss.

There are more than 18 million cancer survivors living in the U.S., but few primary care providers know how to care for this patient group. To close the gap, Houston-based the University of Texas MD Anderson Cancer Center is launching a survivorship training program for primary care providers.

A surgeon at Miami-based Sylvester Comprehensive Cancer Center is the first in the U.S. to use a blue laser to treat early glottic cancer, a common type of laryngeal cancer.

Renton, Wash.-based Providence is launching a first-of-its-kind study to examine the real-world implementation of multi-cancer early-detection blood tests.

Transvaginal ultrasounds fail to detect endometrial cancer in up to 11.4% of Black women, according to research from a Seattle-based University of Washington study published June 27 in JAMA Oncology.

The University of MD Anderson Cancer Center and Rice University, both based in Houston, have launched a Cancer Bioengineering Collaborative, a hub that aims to advance cancer research and accelerate the time it takes to turn findings into clinical use.

Hackathons — events wherein programmers come together for days at a time to solve a problem — are a staple in the technology community. Durham, N.C.-based Duke Health is using a similar model to get high school students excited about the medical field.

Hersey, Pa.-based Penn State Health broke ground on its new cancer center.

In an age of advanced technology and personalized medicine, curing prostate cancer is not always necessary, the Association of American Medical Colleges said in a June 25 article.

Wu Liu, PhD, a medical physicist who created new imaging techniques and radiation treatments for cancer, died May 14 of brain cancer at 51.

Leaders at the American Society of Clinical Oncology published a formal document June 25 that outlines what the group deems as the most appropriate use of artificial intelligence when it comes to clinical oncology care.

There are predicted to be approximately 1.96 million new cancer cases in 2023, with a projected  609,000 deaths, USA Facts reported.

The Hospital of Central Connecticut, part of Hartford (Conn.) Healthcare, has filed an application with the state seeking permission to relocate its medical oncology service in a move it said will better accommodate expansions, the Hartford Business Journal reported June 21.